The decision contradicts the values that the U.K. claims to represent, to say nothing of its supposed support for democracy ...
Not for distribution to U.S. news wire services or dissemination in the United States.
Thrust Flight, a leading U.S. aviation training provider and home of the Zero Time to Airline® program, today announced the ...
The most widely adopted computer language in history, COBOL is now causing a host of problems. It's also dangerously ...
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Argentine affiliate, Laboratorio LKM S.A., and its Mexican affiliate, ...
1d
Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
Additionally, MONJUVI received accelerated approval in the United States in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma ...
Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX-200 across multiple lysosomal storage disorders PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE) -- Polaryx The ...
Hidden instructions in content can subtly bias AI, and our scenario shows how prompt injection works, highlighting the need ...
Steel Dynamics, Inc. (NASDAQ/GS: STLD) today provided first quarter 2026 earnings guidance in the range of $2.73 to ...
Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:00 AM EDTCompany ParticipantsAndrew Obenshain - CEO ...
EssilorLuxottica and Dolce&Gabbana have extended their eyewear licensing agreement through 2050, reinforcing a partnership that began in 2004. The agreement covers the design, manufacturing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results